Showing 1-3 of 3 results
-
Potential Impact of Takeda’s Dengue Vaccine Candidate Reinforced by Long-Term Safety and Efficacy Results
Published on 24/05/2021
» •Takeda’s dengue vaccine candidate (TAK-003) prevented 83.6% of hospitalizations and 62.0% of dengue illness overall, with no identified important safety risks through three years following vaccination in ongoing pivotal Phase 3 TIDES trial • Regulatory filings for TAK-003 progressing in European Union and in many dengue-endemic countries; filing in United States planned for later this year • Dengue is the fastest-spreading mosquito-borne viral disease with an estimated 390 million cases and 500,000 hospitalizations per year globally, with limited options for prevention
-
First local Zika case in Malaysia
News, Published on 04/09/2016
» >> KUALA LUMPUR: Malaysia reported its first locally transmitted case of the mosquito-borne Zika virus yesterday, news likely to add to fears of a full-blown outbreak in the tropical nation.
-
Dengue vaccine: Success in Thailand trials
Jon Fernquest, Published on 26/07/2012
» Complete vaccine & prevention near for this serious disease carried by mosquitoes, 50 to 100 million suffer each year, 20,000 die.
Your recent history
-
Recently searched
-
Recently viewed links